Quick Answer
EXOZYMES INC. reported Research And Development Expense of $3.71 million for the year ending 2025.
- EXOZYMES INC. showed an increase of +98.4% in Research And Development Expense from 2024 to 2025.
- This data is from EXOZYMES INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $27.9 thousand | Q1 2024: $277.6 thousand | Q2 2024: $237.4 thousand | Q3 2024: $723.5 thousand | Q1 2025: $575.0 thousand | Q2 2025: $803.0 thousand | Q3 2025: $1.22 million.
- Over the full 3 years of available data (2023 to 2025), EXOZYMES INC.'s Research And Development Expense has grown by 602.8%.
- Historical annual values: Fiscal year 2025: $3.71 million | Fiscal year 2024: $1.87 million | Fiscal year 2023: $527.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: